CTOs on the Move

Vittamed

www.vittamed.com

 
Vittamed is an early stage medical technology company developing innovative ultrasound-based non-invasive neuro diagnostic and monitoring technologies including the measurement of absolute value of intracranial pressure, real time cerebral blood flow autoregulation and intracranial volumetric wave monitoring.
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.vittamed.com
  • 182 Indian Hill Carlisle
    Massachusetts, MA USA 01741
  • Phone: 1978.254.5160

Executives

Name Title Contact Details

Funding

Vittamed raised $10M on 10/15/2015

Similar Companies

Stimwave Technologies

Stimwave Technologies Inc is a privately-held medical device company engaged in the development, manufacture, commercialization and marketing of wireless microsize injectable medical devices for neurology markets. Stimwave strives to improve people`s lives through utilizing wireless neurostimulation technology that enables low cost alternatives to complicated and expensive surgery, coupled with convenient and safe methods of use easily incorporated into everyday life.

Cyrano Therapeutics

The Cyrano team has developed a unique, proprietary intranasal product to restore function in patients with a chronic loss of taste and smell. This is a condition affecting at least 14 million people in the US and a similar number in Europe, having a significant impact on safety, quality of life and well-being.

Lifeline of Ohio

Lifeline of Ohio is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nu Life Long Island

Nu Life Long Island is a West Hempstead, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EndoChoice

EndoChoice Based in Atlanta GA, EndoChoice® is a medtech company focused on the manufacturing and commercialization of platform technologies including devices, diagnostics, infection control and endoscopic imaging for specialists treating a wide range of gastrointestinal diseases. EndoChoice leverages its direct sales organization to serve more than 2,000 customers in the United States and works with 34 distribution partners world-wide. The Company was founded in 2008 and has rapidly developed a proprietary product portfolio, which includes the revolutionary Full Spectrum Endoscopy® System (Fuse®). 2014 marked the fifth consecutive year EndoChoice was recognized as one of the fastest growing companies in the U.S. by Inc. Magazine.